CURRENT
ISSUE
1540
February 12, 2018
Nonopioid drugs can be used in the treatment of many nociceptive and neuropathic pain conditions. Use of opioids for pain will be reviewed in a future issue....  Continue reading
More from Issue 1540
Previous Issue: 1539      January 29, 2018
Coming Soon
Odactra - Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis
Benralizumab (Fasenra) for Severe Eosinophilic Asthma
Once-Monthly Subcutaneous Buprenorphine (Sublocade) for Opioid Use Disorder
Drugs for Treatment and Prevention of Venous Thromboembolism
Search
Subscribe
Reader Testimonials
Watch the video!
Conversation
Follow us  facebook        Email Alerts
 Tweets
Featured Article
FROM
ISSUE
1539

The FDA has approved a two-dose hepatitis B virus (HBV) vaccine (Heplisav-B – Dynavax) for use in adults ≥18 years old. The three other HBV vaccines marketed in the US are usually administered in 3 doses. Engerix-B and Recombivax HB are licensed for use in persons of all ages. A combination hepatitis A/B vaccine (Twinrix) contains the same hepatitis B component as Engerix-B and is licensed for use only in adults.1

HEPATITIS B VIRUS INFECTION — HBV infection is transmitted through percutaneous or mucosal contact with ... Continue reading